Could a diabetes drug help heart valves? new study investigates
NCT ID NCT05143177
First seen Apr 04, 2026 · Last updated Apr 24, 2026 · Updated 5 times
Summary
This study tests whether the drug DA-1229 (Evogliptin) can slow the buildup of calcium in the aortic valve, a condition called calcific aortic valve disease. About 580 adults with mild to moderate aortic stenosis will take either the drug or a placebo daily for 2 years. The goal is to see if the drug reduces valve calcification and delays the need for valve surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CALCIFIC AORTIC VALVE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aurora Research Institute
Milwaukee, Wisconsin, 53215, United States
-
Baycare Health systems
Safety Harbor, Florida, 34695, United States
-
Beaumont Hospital, Royal Oak
Royal Oak, Michigan, 48073, United States
-
Christ Hospital
Cincinnati, Ohio, 45219, United States
-
Einstein Medical Center Philadelphia
Philadelphia, Pennsylvania, 19141, United States
-
Hackensack Meridian Health
Hackensack, New Jersey, 07601, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Ichan School of Medicine
New York, New York, 10025, United States
-
Inova Health Care Services
Falls Church, Virginia, 22042, United States
-
Institut Universitaire de Cardiologie et de Pneumologie de Québec - Université Laval
Québec, Canada
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Mayo Clinic, AZ
Phoenix, Arizona, 85054, United States
-
Mayo Clinic, FL
Jacksonville, Florida, 32224, United States
-
Northside Hospital
Atlanta, Georgia, 30342, United States
-
OhioHealth Research Institute
Columbus, Ohio, 43214, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Rutgers- Robert Wood Johnson Medical School
New Brunswick, New Jersey, 08901, United States
-
Stony brook
Stony Brook, New York, 11974, United States
-
Texas Heart Institute
Houston, Texas, 77030, United States
-
The University of Vermont Medical Center
Burlington, Vermont, 05401, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Pittsburgh Medical Center
Mechanicsburg, Pennsylvania, 17050, United States
-
University of Southern California
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.